Alicia C. Olivo, EVP, GC & Business Development at NEOGENOMICS INC (NEO), sold 20,916 shares at $12.00 ($251K) on 2025-11-25, disclosed to the SEC on 2025-11-28.
Scheduled sale ($251k) by EVP, GC & Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| NEO | SELL | 2024-08-19 | $17K | — | Filing → |
| NEO | SELL | 2024-05-17 | $17K | — | Filing → |
| NEO | SELL | 2024-02-20 | $39K | — | Filing → |